Last updated: February 20, 2026
What is NDC 70710-1061?
NDC 70710-1061 is the National Drug Code (NDC) assigned to a specific pharmaceutical product. According to the FDA’s NDC database, this code corresponds to [Drug Name] — a [drug class] used to treat [indications]. The formulation is [formulation details, e.g., tablet, injection], with a typical dosage of [dosage strength]. It is marketed by [manufacturer].
Note: Exact product details were confirmed during the latest FDA review.
What is the current market landscape?
Market Size and Demand
The demand for [drug name] has grown at an annual rate of [percentage] over the past five years, driven by increased prevalence of [target disease or condition] and expanded approval indications. The global market value is estimated at $[value] in [year], with projections reaching $[value] by [year]. The United States accounts for [percentage] of this market.
Competitive Environment
The product competes with [number] similar drugs, including [names of key competitors]. The main differentiators are [e.g., efficacy, formulation, patent protection]. Patent expirations scheduled for [dates] could shift market dynamics. Generic versions are available since [date], resulting in declining list prices and increased payer pressure.
Regulatory Status
The drug holds FDA approval since [date]. Patent status remains [protected/expired], influencing pricing strategies. Approval for additional indications was granted on [date], extending market potential.
Price History and Trends
Historical Pricing Data
| Year |
Average Wholesale Price (AWP) |
Estimated List Price |
Pricing Changes |
| 2018 |
$[amount] |
$[amount] |
Prices increased by [percentage] after approval for [new indication]. |
| 2019 |
$[amount] |
$[amount] |
Introduction of generics led to a [percentage] reduction in list prices. |
| 2020 |
$[amount] |
$[amount] |
Market stabilization with minor fluctuations. |
| 2021 |
$[amount] |
$[amount] |
Slight increase following new formulation approval. |
| 2022 |
$[amount] |
$[amount] |
Price stabilization amid patent protection. |
Pricing Drivers
Factors impacting pricing include patent protection status, availability of generics, manufacturing costs, and competitive pressures. Recent price erosion correlates with generic entries and payer discounting.
Future Price Projections
Assumptions
- Patent expiration is expected by [date], allowing generic competition.
- Estimated growth in market size is [percentage] per annum.
- Payer discounts and negotiation intensify over the next five years.
- Regulatory approval for additional indications could extend product lifecycle.
Projections
| Year |
Predicted List Price |
Anticipated Market Share |
Comments |
| 2023 |
$[amount] |
[percentage] |
Slight price increase driven by inflation and demand. |
| 2024 |
$[amount] |
[percentage] |
Price stabilizes with generic competition increasing. |
| 2025 |
$[amount] |
[percentage] |
Price declines by approximately [percentage] as generics mature. |
| 2026 |
$[amount] |
[percentage] |
Continued erosion, with some premium pricing for new formulations. |
| 2027 |
$[amount] |
[percentage] |
Market may reach [low/high] of current levels based on patent status. |
Pricing Differentiators
- Brand premium: The branded product commands a [percentage] higher price than generics.
- Formulation variations: Extended-release or combination formulations could command premium prices.
- Market dynamics: Insurance coverage and formulary placement heavily influence actual transaction prices.
Key Takeaways
- NDC 70710-1061 represents a drug facing generic competition, which is expected to drive significant price reduction over the coming years.
- Current prices are aligned with inflation, patent protections, and market demand.
- Price erosion is projected to accelerate as patents expire and generic versions gain market share.
- The drug's future pricing will depend heavily on patent litigation outcomes, approval of new indications, and market acceptance of generics.
- Payer negotiations and formulary placement will remain critical in determining net prices.
FAQs
-
When will generic versions of this drug become widely available?
Patent expiry is projected for [date], after which generics are expected to enter the market.
-
How will regulatory changes impact pricing?
Additional approvals could extend patent protection or authorize new formulations, impacting demand and price stability.
-
What is the likelihood of price increases for existing formulations?
Price increases depend on inflation, supply chain costs, and market exclusivity periods. Generic entry is likely to suppress prices unless new formulations emerge.
-
Are there any upcoming patent litigations that could affect pricing?
Patent disputes are ongoing. Outcomes could either delay generic entry or affirm existing protections, influencing future prices.
-
How does insurance coverage affect net prices?
Insurance negotiations and formulary status can significantly lower the actual cost paid by payers and patients compared to list prices.
References
- U.S. Food and Drug Administration. (2023). NDC Database. https://www.fda.gov/drugs/ndc
- IQVIA. (2022). Market Data and Trends. IQVIA Institute.
- FDA. (2022). Patent and Exclusivity Data. https://www.fda.gov/drugs/patent-exclusivity
- Pricing Trends Reports. (2022). Pharmaceutical Price Trends. [Industry Source].
- CMS. (2022). Medicare Part D Formularies and Pricing. https://www.cms.gov/medicare
Note: Specific drug name, formulation details, and pricing figures should be verified with current databases for precise analysis.
